Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer
Shen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Journal of Ovarian Research
|
June 27, 2023
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
Xingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study
Xingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
Journal of Ovarian Research
|
February 18, 2025
The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world study
Xingyu Liu, Ming Li, Yingjun Zhao, et al.
Journal of Ovarian Research
|
April 29, 2025
The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer
Xingyu Liu, Ming Li, Yingjun Zhao, et al.
Eclinicalmedicine
|
August 26, 2020
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
Dan Liu, Pengfei Cui, Shaoqing Zeng, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
The first Chinese National Union of Real-world Gynaecological Oncology Research and Patient Management Platform: A retrospective study
Shaoqing Zeng, Jianhua Chi, Jiahao Liu, et al.
Cell
|
July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
Yikai Luo, Yu Xia, Dan Liu, et al.
Med (New York, N.Y.)
|
January 19, 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
Huayi Li, Yu Xu, Xiaofei Jiao, et al.
The Lancet. Digital Health
|
February 26, 2022
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study
Yue Gao, Shaoqing Zeng, Xiaoyan Xu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer
Shen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Journal of Ovarian Research
|
June 27, 2023
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
Xingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study
Xingyu Liu, Yingjun Zhao, Xiaofei Jiao, et al.
Journal of Ovarian Research
|
February 18, 2025
The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world study
Xingyu Liu, Ming Li, Yingjun Zhao, et al.
Journal of Ovarian Research
|
April 29, 2025
The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer
Xingyu Liu, Ming Li, Yingjun Zhao, et al.
Eclinicalmedicine
|
August 26, 2020
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
Dan Liu, Pengfei Cui, Shaoqing Zeng, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
The first Chinese National Union of Real-world Gynaecological Oncology Research and Patient Management Platform: A retrospective study
Shaoqing Zeng, Jianhua Chi, Jiahao Liu, et al.
Cell
|
July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
Yikai Luo, Yu Xia, Dan Liu, et al.
Med (New York, N.Y.)
|
January 19, 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
Huayi Li, Yu Xu, Xiaofei Jiao, et al.
The Lancet. Digital Health
|
February 26, 2022
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study
Yue Gao, Shaoqing Zeng, Xiaoyan Xu, et al.
Page
of 4